The success of Sildenafil initially sparked a boom for the drug industry, but recent shifts present a murky picture for those considering a stake. Off-patent versions are reducing earnings, and continued patent https://alyshadofk922027.blogvivi.com/41775745/the-blue-pill-and-the-pharmaceutical-industry-a-precarious-investment